About
Noctrix Health, Inc. is a medical technology company founded in 2018, dedicated to developing clinically validated wearable therapeutics for managing chronic neurological disorders, particularly Restless Legs Syndrome (RLS). The company was established with insights from Stanford’s Biodesign Innovation Program and is co-founded by experts in neuromodulation and medical device design. Their flagship product, Nidra, is a prescription-grade wearable device that delivers Tonic Motor Activation therapy. It has received FDA Breakthrough Device Designation and De Novo clearance, highlighting its clinical validation. Noctrix Health focuses on providing non-pharmaceutical, evidence-based therapies that enhance patient outcomes and quality of life. They serve patients with chronic neurological conditions, healthcare providers, and healthcare systems, ensuring broader access through dedicated reimbursement codes. In addition to product development, Noctrix Health conducts clinical trials and research, and offers patient support programs. The company emphasizes safety, privacy, and ethical standards in its operations, aiming to improve the lives of patients through innovative, drug-free treatment alternatives.
Technologies
Keywords
Company Information
-
Employees 110
-
Founded 2018
-
Annual Revenue $2500000
-
Total Funding $57000000
Location
6700 Koll Center Pkwy, Pleasanton, California, United States, 94566-7004